6th Imaging in Drug Discovery
Register 3 attendees for the price of 2 with the coupon code RCDVB!

Dear Colleague,

GTC's 6th Imaging in Drug Discovery & Development Conference, one of four parallel tracks that is featured in a summit on May 8-10, 2013 in Boston, MA, is the only imaging conference that brings together high-level/influential leaders with decision-making authority from the pharmaceutical industry, academia, and government to share their knowledge and expertise in drug discovery and development . Our approach offers a more intimate and networking-oriented environment that is geared towards connecting scientists and researchers who use single- and multimodal imaging applications to further collaborate and advance their imaging projects in drug discovery and development.

Session topics include:

I. Advantages and Challenges of Available Imaging Modalities
        II. Translational Imaging Applications: Preclinical to Clinical
        III. Imaging Applications Across Multiple Therapeutic Areas
        IV. Molecular Imaging and Diagnostic Approaches and Capabilities
        V. High Content Imaging, Quantitative Imaging and Modeling Capabilities

To view the agenda, click here.
To view the speaker list, click here.

The conference will run parallel with 3 other information-packed conferences as part of the Drug Discovery Summit 2013:

        7th Drug Design and Medicinal Chemistry
        3rd Epigenetics in Drug Discovery
        Orphan Drugs Research and Commercialization

Sign up for the summit pass and get access to all 5 tracks in the summit! Or register 3 attendees for the price of 2 by entering coupon code RCDVB when you sign up!

We look forward to seeing you at the 6th Imaging in Drug Discovery and Development Conference in Boston!

Best regards,

The 2013 Advisory Committee

Attend ALL GTC Conferences for One Year for only $3,995 ($1,990 for Acad/Govt). Click here to sign up!

What Past Delegates Said About the Event:

"Intimate conference with plenty of opportunity to interact with colleagues" - David Raunig at Pfizer

"Very efficient and high level conference of a moderate size. The latter provides great possibility to communicate and discuss." - Irina Velikyan, PhD, Scientist, Uppsala University